Kleresca® Acne Treatment

Kleresca^® Acne Treatment

Learn about the treatment and the science behind Kleresca^® Acne Treatment

How the treament works

Kleresca^® Acne Treatment uses fluorescent light energy (FLE) to stimulate the skin’s own repair mechanisms^2-12.
The treatment is based on the interaction between a specially designed photoconverter gel and the Kleresca^® Light^1-3,12.
The chromophores in the gel convert the blue light from the lamp into fluorescent light energy that covers the spectra from green over yellow and orange to red (approx. 510 – 610 nm) at once^2,3,12.
The fluorescence generated (dynamic, ultrafast pulsing light) penetrates the multiple layers of the skin,triggering documented healing responses^2,3,12-16.

Watch video

Stimulate the skin’s own repair mechanisms

Kleresca^® Acne Treatment uses fluorescent light energy (FLE) to enhance overall skin quality and reduce the appearance of scars^2-12.
Discover a gentle, painless, and non-destructive alternative to drugs and invasive procedures^2-12.

Treats both active acne and acne scarring
Normalises the skin
Non-systemic, lasting up to a year and above
Suitable all year-round, including summer

See how the treatment works

How the treatment is performed

Patients typically describe the three-step treatment as a pleasant experience^2-12. It only takes nine minutes under the lamp¹. With little to no downtime, make-up can be applied immediately after the session^1,12.

1. The skin is cleaned and Kleresca^® Acne Treatment gel is applied

2. The gel is illuminated for nine minutes using the Kleresca^® Light; fluorescent light energy (FLE) is created stimulating the skin’s own repair mechanism

3. The gel is removed and the skin is cleansed and moisturized.

High-efficiency and painless^2-6

In a randomised, multi-centre, split-face clinical trial with patients suffering from moderate to severe acne, patients were followed during treatment (twice per week for 6 weeks) and afterwards for an additional 6 weeks in order to study the long-lasting effects⁵.

Read the summary

Clinical trial results⁵:
89% response rate (patients ≥ 1 IGA* grade improvement)
52% of patients with ≥ 2 IGA grades improvement
33 % of patients reached clear or almost clear skin
81% of patients ≥ 40% reduction in inflammatory acne lesion counts
No serious adverse events reported
All adverse events were transient and did not require any intervention by the clinic

Conclusions:
The treatment was considered to be well-tolerated, with no serious adverse events
Patients’ quality of life improved
The treatment was found to be efficacious and safe

52% of patients with ≥ 2 IGA grades improvement

33 % of patients reached clear or almost clear skin

81% of patients ≥ 40% reduction in inflammatory acne lesion counts

Most frequent TEAEs* occurring with >5% frequency

Sustained efficacy⁴

Robust data from an extension trial confirms the high efficacy and persistence of Kleresca^® Acne Treatment.

Read the summary

Clinical trial results⁴:
Persistence of efficacy was demonstrated for at least six months, with the two grade or better improvement from the first trial maintained in 92% of patients. No patients reverted back to baseline. Patient safety profile was also excellent, with very few related adverse events. Based on experience from current clinics, patients treated with Kleresca^® Acne Treatment show results lasting up to a year or above.

Conclusions:
"Study confirmed the long duration of effect following treatment"
"Patient safety profile was excellent, with very few related adverse events"
"Kleresca^® Acne Treatment provides long-term efficacy and safety in the treatment of acne vulgaris, with a rate of compliance above what is generally observed in a young population"

Safety information

The Kleresca^® Acne Treatment takes place on your skin and is not absorbed or metabolised, making it a well-tolerated treatment option for acne.
In clinical trials, Kleresca^® Acne Treatment showed high safety with no serious adverse events, and the treatment itself was considered to be a pleasant and comfortable experience. Side effects seen in those treated include, redness, hyperpigmentation (bronzing of an area of the skin) and slight discoloration of hair in some cases where the gel was applied covering facial hair. All side effects were transient and did not require any intervention by the clinic.
Side effects impact patients differently depending on the skin type.
Kleresca^® Acne Treatment is not recommended in the following situations:
1. Patients taking drugs or products (e.g. retinoids) or with conditions (e.g. porphyria) known to induce photosensitive reaction.
2. Patients with known skin hypersensitivity.

*For references click here

Name

Title

forms.patientsignup.address

Name of clinic (optional)

Phone

City

Comment

Country

By clicking Submit, you agree to our Website terms of use

Distributed by:

Klox Technologies Europe Limited
51 Bracken Road
Sandyford Industrial Estate
Dublin 18
Ireland

Corp Reg.no.: IE 595931
All trademarks, including Kleresca, mentioned belong to FB Dermatology Ltd.

Contact us

We would like to hear from you! Click here to contact us

Info